Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Britta Höchsmann

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Hematology/Oncology Clinics of North America|June 5, 2015
Congenital CD59 DeficiencyBritta Höchsmann, Hubert Schrezenmeier
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 16, 2011
Drugs that inhibit complementHubert Schrezenmeier, Britta Höchsmann
Expert Review of Hematology|November 19, 2010
Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuriaHubert Schrezenmeier, Britta Höchsmann
Annals of Hematology|March 2, 2011
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytesBritta Höchsmann, Markus Rojewski, Hubert Schrezenmeier
Expert Review of Hematology|January 10, 2015
Immunosuppressive therapy for transplant-ineligible aplastic anemia patientsHubert Schrezenmeier, Sixten Körper, Britta Höchsmann
European Journal of Immunology|August 5, 2024
The complement model disease paroxysmal nocturnal hemoglobinuriaChristoph Q Schmidt, Britta Höchsmann, Hubert Schrezenmeier
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and TreatmentJens Peter Panse, Britta Höchsmann, Jörg Schubert
The New England Journal of Medicine|January 3, 2014
Targeted therapy with eculizumab for inherited CD59 deficiencyBritta Höchsmann, Christian Dohna-Schwake, Henriette A Kyrieleis, et al.
Annals of Hematology|February 14, 2013
Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in GermanySteffen Heublein, Franziska Wehner, Britta Höchsmann, et al.
Transfusion|September 25, 2014
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusionChristof Weinstock, Robert Möhle, Christiane Dorn, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Hematology/Oncology Clinics of North America|June 5, 2015
Congenital CD59 DeficiencyBritta Höchsmann, Hubert Schrezenmeier
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|December 16, 2011
Drugs that inhibit complementHubert Schrezenmeier, Britta Höchsmann
Expert Review of Hematology|November 19, 2010
Eculizumab opens a new era of treatment for paroxysmal nocturnal hemoglobinuriaHubert Schrezenmeier, Britta Höchsmann
Annals of Hematology|March 2, 2011
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytesBritta Höchsmann, Markus Rojewski, Hubert Schrezenmeier
Expert Review of Hematology|January 10, 2015
Immunosuppressive therapy for transplant-ineligible aplastic anemia patientsHubert Schrezenmeier, Sixten Körper, Britta Höchsmann
European Journal of Immunology|August 5, 2024
The complement model disease paroxysmal nocturnal hemoglobinuriaChristoph Q Schmidt, Britta Höchsmann, Hubert Schrezenmeier
Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|October 7, 2024
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and TreatmentJens Peter Panse, Britta Höchsmann, Jörg Schubert
The New England Journal of Medicine|January 3, 2014
Targeted therapy with eculizumab for inherited CD59 deficiencyBritta Höchsmann, Christian Dohna-Schwake, Henriette A Kyrieleis, et al.
Annals of Hematology|February 14, 2013
Modelling cost effectiveness of horse antithymocyte globulin for treating severe aplastic anaemia in GermanySteffen Heublein, Franziska Wehner, Britta Höchsmann, et al.
Transfusion|September 25, 2014
Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO-incompatible red blood cell transfusionChristof Weinstock, Robert Möhle, Christiane Dorn, et al.
Pageof 6